Profiling networks of distinct immune-cells in tumors. Clancy, T. & Hovig, E. Paper Website abstract bibtex Background: It is now clearly evident that cancer outcome and response to therapy is guided by diverse immune-cell activity in tumors. Presently, a key challenge is to comprehensively identify networks of distinct immune-cell signatures present in complex tissue, at higher-resolution and at various stages of differentiation, activation or function. This is particularly so for closely related immune-cells with diminutive, yet critical, differences. Results: To predict networks of infiltrated distinct immune-cell phenotypes at higher resolution, we explored an integrated knowledge-based approach to select immune-cell signature genes integrating not only expression enrichment across immune-cells, but also an automatic capture of relevant immune-cell signature genes from the literature. This knowledge-based approach was integrated with resources of immune-cell specific protein networks, to define signature genes of distinct immune-cell phenotypes. We demonstrate the utility of this approach by profiling signatures of distinct immune-cells, and networks of immune-cells, from metastatic melanoma patients who had undergone chemotherapy. The resultant bioinformatics strategy complements immunohistochemistry from these tumors, and predicts both tumor-killing and immunosuppressive networks of distinct immune-cells in responders and non-responders, respectively. The approach is also shown to capture differences in the immune-cell networks of BRAF versus NRAS mutated metastatic melanomas, and the dynamic changes in resistance to targeted kinase inhibitors in MAPK signalling. Conclusions: This integrative bioinformatics approach demonstrates that capturing the protein network signatures and ratios of distinct immune-cell in the tumor microenvironment maybe an important factor in predicting response to therapy. This may serve as a computational strategy to define network signatures of distinct immune-cells to guide immuno-pathological discovery.
@article{
title = {Profiling networks of distinct immune-cells in tumors},
type = {article},
identifiers = {[object Object]},
keywords = {Cancer,Immune informatics,Immune profiling,Immune-cell infiltration Background,Personalized medicine,Protein interaction networks,Transcriptomics},
websites = {https://link.springer.com/content/pdf/10.1186%2Fs12859-016-1141-3.pdf},
id = {d2f73129-3679-3ca6-836c-efe3415dd900},
created = {2018-07-11T13:29:19.651Z},
accessed = {2018-07-11},
file_attached = {true},
profile_id = {b63e8b24-ed73-38a0-835d-fc93fa76b2df},
group_id = {7cefe685-317a-3d95-8344-b52e9a2517ff},
last_modified = {2018-10-25T21:47:39.553Z},
read = {false},
starred = {false},
authored = {false},
confirmed = {false},
hidden = {false},
citation_key = {Clancy},
private_publication = {false},
abstract = {Background: It is now clearly evident that cancer outcome and response to therapy is guided by diverse immune-cell activity in tumors. Presently, a key challenge is to comprehensively identify networks of distinct immune-cell signatures present in complex tissue, at higher-resolution and at various stages of differentiation, activation or function. This is particularly so for closely related immune-cells with diminutive, yet critical, differences. Results: To predict networks of infiltrated distinct immune-cell phenotypes at higher resolution, we explored an integrated knowledge-based approach to select immune-cell signature genes integrating not only expression enrichment across immune-cells, but also an automatic capture of relevant immune-cell signature genes from the literature. This knowledge-based approach was integrated with resources of immune-cell specific protein networks, to define signature genes of distinct immune-cell phenotypes. We demonstrate the utility of this approach by profiling signatures of distinct immune-cells, and networks of immune-cells, from metastatic melanoma patients who had undergone chemotherapy. The resultant bioinformatics strategy complements immunohistochemistry from these tumors, and predicts both tumor-killing and immunosuppressive networks of distinct immune-cells in responders and non-responders, respectively. The approach is also shown to capture differences in the immune-cell networks of BRAF versus NRAS mutated metastatic melanomas, and the dynamic changes in resistance to targeted kinase inhibitors in MAPK signalling. Conclusions: This integrative bioinformatics approach demonstrates that capturing the protein network signatures and ratios of distinct immune-cell in the tumor microenvironment maybe an important factor in predicting response to therapy. This may serve as a computational strategy to define network signatures of distinct immune-cells to guide immuno-pathological discovery.},
bibtype = {article},
author = {Clancy, Trevor and Hovig, Eivind}
}
Downloads: 0
{"_id":"s8JvEfgafgDGxyQrP","bibbaseid":"clancy-hovig-profilingnetworksofdistinctimmunecellsintumors","downloads":0,"creationDate":"2019-03-08T20:39:38.656Z","title":"Profiling networks of distinct immune-cells in tumors","author_short":["Clancy, T.","Hovig, E."],"year":null,"bibtype":"article","biburl":null,"bibdata":{"title":"Profiling networks of distinct immune-cells in tumors","type":"article","identifiers":"[object Object]","keywords":"Cancer,Immune informatics,Immune profiling,Immune-cell infiltration Background,Personalized medicine,Protein interaction networks,Transcriptomics","websites":"https://link.springer.com/content/pdf/10.1186%2Fs12859-016-1141-3.pdf","id":"d2f73129-3679-3ca6-836c-efe3415dd900","created":"2018-07-11T13:29:19.651Z","accessed":"2018-07-11","file_attached":"true","profile_id":"b63e8b24-ed73-38a0-835d-fc93fa76b2df","group_id":"7cefe685-317a-3d95-8344-b52e9a2517ff","last_modified":"2018-10-25T21:47:39.553Z","read":false,"starred":false,"authored":false,"confirmed":false,"hidden":false,"citation_key":"Clancy","private_publication":false,"abstract":"Background: It is now clearly evident that cancer outcome and response to therapy is guided by diverse immune-cell activity in tumors. Presently, a key challenge is to comprehensively identify networks of distinct immune-cell signatures present in complex tissue, at higher-resolution and at various stages of differentiation, activation or function. This is particularly so for closely related immune-cells with diminutive, yet critical, differences. Results: To predict networks of infiltrated distinct immune-cell phenotypes at higher resolution, we explored an integrated knowledge-based approach to select immune-cell signature genes integrating not only expression enrichment across immune-cells, but also an automatic capture of relevant immune-cell signature genes from the literature. This knowledge-based approach was integrated with resources of immune-cell specific protein networks, to define signature genes of distinct immune-cell phenotypes. We demonstrate the utility of this approach by profiling signatures of distinct immune-cells, and networks of immune-cells, from metastatic melanoma patients who had undergone chemotherapy. The resultant bioinformatics strategy complements immunohistochemistry from these tumors, and predicts both tumor-killing and immunosuppressive networks of distinct immune-cells in responders and non-responders, respectively. The approach is also shown to capture differences in the immune-cell networks of BRAF versus NRAS mutated metastatic melanomas, and the dynamic changes in resistance to targeted kinase inhibitors in MAPK signalling. Conclusions: This integrative bioinformatics approach demonstrates that capturing the protein network signatures and ratios of distinct immune-cell in the tumor microenvironment maybe an important factor in predicting response to therapy. This may serve as a computational strategy to define network signatures of distinct immune-cells to guide immuno-pathological discovery.","bibtype":"article","author":"Clancy, Trevor and Hovig, Eivind","bibtex":"@article{\n title = {Profiling networks of distinct immune-cells in tumors},\n type = {article},\n identifiers = {[object Object]},\n keywords = {Cancer,Immune informatics,Immune profiling,Immune-cell infiltration Background,Personalized medicine,Protein interaction networks,Transcriptomics},\n websites = {https://link.springer.com/content/pdf/10.1186%2Fs12859-016-1141-3.pdf},\n id = {d2f73129-3679-3ca6-836c-efe3415dd900},\n created = {2018-07-11T13:29:19.651Z},\n accessed = {2018-07-11},\n file_attached = {true},\n profile_id = {b63e8b24-ed73-38a0-835d-fc93fa76b2df},\n group_id = {7cefe685-317a-3d95-8344-b52e9a2517ff},\n last_modified = {2018-10-25T21:47:39.553Z},\n read = {false},\n starred = {false},\n authored = {false},\n confirmed = {false},\n hidden = {false},\n citation_key = {Clancy},\n private_publication = {false},\n abstract = {Background: It is now clearly evident that cancer outcome and response to therapy is guided by diverse immune-cell activity in tumors. Presently, a key challenge is to comprehensively identify networks of distinct immune-cell signatures present in complex tissue, at higher-resolution and at various stages of differentiation, activation or function. This is particularly so for closely related immune-cells with diminutive, yet critical, differences. Results: To predict networks of infiltrated distinct immune-cell phenotypes at higher resolution, we explored an integrated knowledge-based approach to select immune-cell signature genes integrating not only expression enrichment across immune-cells, but also an automatic capture of relevant immune-cell signature genes from the literature. This knowledge-based approach was integrated with resources of immune-cell specific protein networks, to define signature genes of distinct immune-cell phenotypes. We demonstrate the utility of this approach by profiling signatures of distinct immune-cells, and networks of immune-cells, from metastatic melanoma patients who had undergone chemotherapy. The resultant bioinformatics strategy complements immunohistochemistry from these tumors, and predicts both tumor-killing and immunosuppressive networks of distinct immune-cells in responders and non-responders, respectively. The approach is also shown to capture differences in the immune-cell networks of BRAF versus NRAS mutated metastatic melanomas, and the dynamic changes in resistance to targeted kinase inhibitors in MAPK signalling. Conclusions: This integrative bioinformatics approach demonstrates that capturing the protein network signatures and ratios of distinct immune-cell in the tumor microenvironment maybe an important factor in predicting response to therapy. This may serve as a computational strategy to define network signatures of distinct immune-cells to guide immuno-pathological discovery.},\n bibtype = {article},\n author = {Clancy, Trevor and Hovig, Eivind}\n}","author_short":["Clancy, T.","Hovig, E."],"urls":{"Paper":"https://bibbase.org/service/mendeley/b63e8b24-ed73-38a0-835d-fc93fa76b2df/file/28c66ff9-0ede-e5f1-11e5-dd9997d8abf4/Profiling_networks_of_distinct_immune-cells_in_tumors.pdf.pdf","Website":"https://link.springer.com/content/pdf/10.1186%2Fs12859-016-1141-3.pdf"},"bibbaseid":"clancy-hovig-profilingnetworksofdistinctimmunecellsintumors","role":"author","keyword":["Cancer","Immune informatics","Immune profiling","Immune-cell infiltration Background","Personalized medicine","Protein interaction networks","Transcriptomics"],"downloads":0,"html":""},"search_terms":["profiling","networks","distinct","immune","cells","tumors","clancy","hovig"],"keywords":["cancer","immune informatics","immune profiling","immune-cell infiltration background","personalized medicine","protein interaction networks","transcriptomics"],"authorIDs":[]}